3593 On Other Exchanges
Symbol
Exchange
3593 is not on other exchanges.

hogy medical co ltd (3593) Snapshot

Open
--
Previous Close
--
Day High
--
Day Low
--
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
--
Average Volume 10 Days
--
EPS TTM
--
Shares Outstanding
--
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for HOGY MEDICAL CO LTD (3593)

Related News

No related news articles were found.

hogy medical co ltd (3593) Related Businessweek News

No Related Businessweek News Found

hogy medical co ltd (3593) Details

Hogy Medical Co., Ltd. develops and supplies various medical products for healthcare facilities in Japan and internationally. It offers kit products for surgery applications; and non-woven products comprising gowns, caps, underwear, drapes, packaged products, equipment covers, kurumu, towels, masks, caps, isolation gowns, and accessories for use in operating rooms, outpatient areas, hospital wards, and other areas, as well as provides Tigalyer, a multi-layer fabric material. The company also provides sterilization products, such as hybrid Mekkin bags, hybrid Mekkin bags ID layered type, and Autoclave Forceps stand caps; Mekkin cards, which are detection cards used to judge the sterilization process when sterilizing in an autoclave; ethylene oxide gas cards that are detection cards used to judge the sterilization process when sterilizing using ethylene oxide gas; and indicator tapes for autoclave sterilization. In addition, it offers IC Tracer, a gauze control system that uses integrated circuit chips embedded in each gauze used during surgery, making each one traceable; ASRC, which is made of a foamed polyethylene sponge that provides flexibility and functionality for use in varying procedures and inosculations of pancreaticoduodenectomy; SECUREA, a sponge for endoscopic surgery; and Opera Master, a system to specifically support medical facilities for collecting various information related to the surgery rooms. The company was formerly known as Hogy Co., Ltd. and changed its name to Hogy Medical Co., Ltd. in 1987. Hogy Medical Co., Ltd. was founded in 1955 and is headquartered in Tokyo, Japan.

1,521 Employees
Last Reported Date: 06/24/16
Founded in 1955

hogy medical co ltd (3593) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

hogy medical co ltd (3593) Key Developments

Hogy Medical Co. Ltd. Reports Consolidated Earnings Results for the First Quarter Ended June 30, 2016; Provides Earnings Guidance for the First Two Quarters of 2016; Provides Earnings Guidance for the Year 2016; Announces Dividend for the First Quarter Ended June 30, 2016, Payable on August 31, 2016; Provides Dividend Guidance for the Second Quarter and Third Quarter of 2016; Provides Dividend Guidance for the Year 2016

Hogy Medical Co. Ltd. reported consolidated earnings results for the first quarter ended June 30, 2016. For the quarter, the company reported net sales of ¥9,055 million against ¥8,639 million a year ago. Operating income was ¥2,083 million against ¥2,147 million a year ago. Ordinary income was ¥2,065 million against ¥2,195 million a year ago. Income before income taxes was ¥2,065 million against ¥2,197 million a year ago. Profit was ¥1,428 million against ¥1,491 million a year ago. Profit attributable to owners of parent was ¥1,428 million against ¥1,491 million a year ago. Net cash provided by operating activities was ¥3,494 million against ¥962 million a year ago. Purchase of tangible fixed assets was ¥1,271 million against ¥8,222 million a year ago. Purchase of intangible fixed assets was ¥295 million against ¥209 million a year ago. Profit per share was ¥90.84 against ¥94.83 per share a year ago. For the first quarter of fiscal 2016, the company announced dividend of ¥30.00 per share against ¥29.00 per share a year ago. The dividend will be payable on August 31, 2016. For the second quarter, the company expects to pay dividend of ¥30.00 per share against ¥29.00 per share a year ago. For the third quarter, the company expects to pay dividend of ¥30.00 per share against ¥29.00 per share a year ago. For the year, the company expects to pay dividend of ¥30.00 per share against ¥29.00 per share a year ago. For the full year, the company expects to pay dividend of ¥116.00 per share against ¥120.00 per share a year ago. For the first two quarters, the company expects net sales of ¥18,490 million, operating income of ¥3,570 million, ordinary income of ¥3,650 million, profit attributable to owners of parent of ¥2,520 million or ¥160.22 per share. For the year, the company expects net sales of ¥38,400 million, operating income of ¥7,180 million, ordinary income of ¥7,280 million, profit attributable to owners of parent of ¥5,000 million or ¥317.90 per share.

Hogy Medical Co. Ltd. to Report Q1, 2017 Results on Jul 12, 2016

Hogy Medical Co. Ltd. announced that they will report Q1, 2017 results on Jul 12, 2016

Hogy Medical Co. Ltd. Reports Consolidated and Non-Consolidated Earnings Results for the Year Ended March 31, 2016; Provides Consolidated and Non-Consolidated Earnings Guidance for the First Six Months of Fiscal Year 2017 and Year Ending March 31, 2017

Hogy Medical Co. Ltd. reported consolidated and non-consolidated earnings results for the year ended March 31, 2016. For the year, on consolidated basis, the company reported net sales of JPY 36,568 million against JPY 35,233 million a year ago. Operating income was JPY 8,784 million against JPY 8,505 million a year ago. Ordinary income was JPY 8,924 million against JPY 8,768 million a year ago. Profit attributable to owners of parent was JPY 5,910 million or JPY 375.81 per share compared to JPY 5,659 million or JPY 359.81 per share for the same period a year ago. Income before income taxes was JPY 8,743 million compared to JPY 8,678 million a year ago. Net cash provided by operating activities was JPY 6,809 million compared to JPY 7,935 million a year ago. Purchase of tangible fixed assets was JPY 14,690 million compared to JPY 10,525 million a year ago. Purchase of intangible fixed assets was JPY 1,094 million compared to JPY 1,266 million a year ago. For the year, on non-consolidated basis, the company reported total net sales of JPY 36,320 million against JPY 34,985 million a year ago. Operating income was JPY 7,729 million against JPY 7,651 million a year ago. Ordinary income was JPY 7,997 million against JPY 8,030 million a year ago. Net income was JPY 5,249 million or JPY 333.74 per share compared to JPY 5,142 million or JPY 326.95 per share for the same period a year ago. Income before income taxes was JPY 7,814 million compared to JPY 7,939 million a year ago. The company provided consolidated and non-consolidated earnings guidance for the first six months of fiscal year 2017 and year ending March 31, 2017. For the six months, on consolidated basis, expects net sales of JPY 18,490 million, operating income of JPY 3,570 million, ordinary income of JPY 3,650 million and net income of JPY 2,520 million or JPY 160.22 per share. For the year, on consolidated basis expects net sales of JPY 38,400 million, operating income of JPY 7,180 million, ordinary income of JPY 7,280 million and net income of JPY 5,000 million or JPY 317.90 per share. For the six months, on non-consolidated basis, expects net sales of JPY 18,350 million, operating income of JPY 3,040 million, ordinary income of JPY 3,120 million and net income of JPY 2,140 million or JPY 136.06 per share. For the year, on non-consolidated basis expects net sales of JPY 38,110 million, operating income of JPY 6,320 million, ordinary income of JPY 6,510 million and net income of JPY 4,460 million or JPY 283.56 per share.

 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

3593 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 3593.
View Industry Companies
 

Industry Analysis

3593

Industry Average

Valuation 3593 Industry Range
Price/Earnings 18.9x
Price/Sales 3.0x
Price/Book 1.3x
Price/Cash Flow 16.7x
TEV/Sales 2.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact HOGY MEDICAL CO LTD, please visit www.hogy.co.jp. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.